Skip Nav Destination
Issues
August 2014
-
Cover Image
Cover Image
- PDF Icon PDF LinkFront Matter
ISSN 0001-5792
EISSN 1421-9662
In this Issue
Acta Haematologica 2014, Vol. 132, No. 2
Brief Communication
Bone Marrow Expression of CCL3 Is Not Correlated with the Extent of Lytic Bone Lesions
Acta Haematol (2014) 132 (2): 129–133.
https://doi.org/10.1159/000357101
Case Report
der(5;17)(p10;q10) Is a Recurrent But Rare Whole-Arm Translocation in Patients with Hematological Neoplasms: A Report of Three Cases
Masahiro Manabe; Junya Okita; Teruhito Takakuwa; Naonori Harada; Yasutaka Aoyama; Takeo Kumura; Tadanobu Ohta; Yoshio Furukawa; Atsuko Mugitani
Acta Haematol (2014) 132 (2): 134–139.
https://doi.org/10.1159/000357111
Brief Communication
Original Paper
Characteristics and Clinical Evolution of Patients with Acute Myeloblastic Leukemia in Northeast Mexico: An Eight-Year Experience at a University Hospital
José Carlos Jaime-Pérez; Alma Sirenia Brito-Ramirez; Monica Andrea Pinzon-Uresti; Homero Gutiérrez-Aguirre; Olga G. Cantú-Rodríguez; José Luis Herrera-Garza; David Gomez-Almaguer
Acta Haematol (2014) 132 (2): 144–151.
https://doi.org/10.1159/000356794
Echocardiography-Derived Tricuspid Regurgitant Jet Velocity Is an Important Marker for the Progression of Sickle-Cell Disease
Acta Haematol (2014) 132 (2): 152–158.
https://doi.org/10.1159/000357393
Brief Communication
Case Report
A Case of Gray Platelet Syndrome Masked by Immune Thrombocytopenia at Presentation
Acta Haematol (2014) 132 (2): 163–165.
https://doi.org/10.1159/000357371
Original Paper
CD117 (c-kit) Expression on CD34+ Cells Participates in the Cytogenetic Response to Imatinib in Patients with Chronic Myeloid Leukemia in the First Chronic Phase
Jaroslaw Dybko; Olga Haus; Bożena Jaźwiec; Joanna Urbaniak; Mieczysław Woźniak; Agnieszka Kaczmar-Dybko; Donata Urbaniak-Kujda; Katarzyna Kapelko-Slowik; Kazimierz Kuliczkowski
Acta Haematol (2014) 132 (2): 166–171.
https://doi.org/10.1159/000357373
Increased 14-3-3ζ Expression in the Multidrug-Resistant Leukemia Cell Line HL-60/VCR as Compared to the Parental Line Mediates Cell Growth and Apoptosis in Part through Modification of Gene Expression
Rong Liang; Xie-Qun Chen; Qin-Xian Bai; Zhe Wang; Tao Zhang; Lan Yang; Bao-Xia Dong; Guang-Xun Gao; Hong-Tao Gu; Hua-Feng Zhu
Acta Haematol (2014) 132 (2): 177–186.
https://doi.org/10.1159/000357377
Case Report
Editorial Comment
Endothelial Microparticles and Endothelial Damage: ‘The Tip and the Iceberg'
Acta Haematol (2014) 132 (2): 199.
https://doi.org/10.1159/000360600
Original Paper
Carvedilol Protects against Iron-Induced Microparticle Generation and Apoptosis of Endothelial Cells
Acta Haematol (2014) 132 (2): 200–210.
https://doi.org/10.1159/000356808
Survival of Multiple Myeloma Patients Aged 65-70 Years in the Era of Novel Agents and Autologous Stem Cell Transplantation: A Multicenter Retrospective Collaborative Study of the Japanese Society of Myeloma and the European Myeloma Network
Shuji Ozaki; Takeshi Harada; Takayuki Saitoh; Chihiro Shimazaki; Mitsuhiro Itagaki; Hideki Asaoku; Yoshiaki Kuroda; Takaaki Chou; Yumiko Yoshiki; Kenshi Suzuki; Hirokazu Murakami; Kunihiko Hayashi; Roberto Mina; Antonio Palumbo; Kazuyuki Shimizu; on behalf of the Japanese Society of Myeloma and the European Myeloma Network
Acta Haematol (2014) 132 (2): 211–219.
https://doi.org/10.1159/000357394
Case Report
Initially Lymphocytic Sweet's Syndrome in Male Patients with Myelodysplasia: A Distinguished Clinicopathological Entity? Case Report and Systematic Review of the Literature
Nikolaos Kakaletsis; Georgia Kaiafa; Christos Savopoulos; Fotios Iliadis; Vasilios Perifanis; Vasilios Tzalokostas; Alexandra Grekou; Angeliki Giannouli; Apostolos I. Hatzitolios
Acta Haematol (2014) 132 (2): 220–225.
https://doi.org/10.1159/000357933
Original Paper
Rapid Communication
Utilization of Magnetic-Activated Cell Sorting and High-Density Single Nucleotide Polymorphism Microarrays Improves Diagnostic Yield and Prognostic Value in Clinical Testing for Patients with Multiple Myeloma and Normal Routine Chromosome Study
Todd Christensen; Weiwen Deng; Bonnie McMahill; Joseph Schappert; Weihua Liu; Reza Saleki; Ying S. Zou
Acta Haematol (2014) 132 (2): 233–236.
https://doi.org/10.1159/000361074
Editorial Comment
Alemtuzumab and Treatment of Chronic Lymphocytic Leukemia and Its Immune-Related Disorders: One Player on Two Tables
Acta Haematol (2014) 132 (2): 237–239.
https://doi.org/10.1159/000359949
Case Report
Successful Treatment of Refractory Guillain-Barré Syndrome with Alemtuzumab in a Patient with Chronic Lymphocytic Leukemia
Acta Haematol (2014) 132 (2): 240–243.
https://doi.org/10.1159/000358292
Brief Communication
Original Paper
Thrombolytic Effects in vivo of Nattokinase in a Carrageenan-Induced Rat Model of Thrombosis
Acta Haematol (2014) 132 (2): 247–253.
https://doi.org/10.1159/000360360
Editorial Comment
Adding Selenium to Chemotherapy and Radiation in Haematological Malignancies: Clinical Trials Are Justified
Acta Haematol (2014) 132 (2): 254–255.
https://doi.org/10.1159/000362496
Brief Communication
Serum Selenium Deficiency in Patients with Hematological Malignancies: Is a Supplementation Study Mandatory?
Ralph Muecke; Oliver Micke; Lutz Schomburg; Jens Buentzel; Irenaeus A. Adamietz; Jutta Huebner; on behalf of the German Working Group Trace Elements and Electrolytes in Oncology (AKTE)
Acta Haematol (2014) 132 (2): 256–258.
https://doi.org/10.1159/000360903
